Literature DB >> 11035112

Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice.

H Noorchashm1, D J Moore, L E Noto, N Noorchashm, A J Reed, A L Reed, H K Song, R Mozaffari, A M Jevnikar, C F Barker, A Naji.   

Abstract

Diabetes in nonobese diabetic (NOD) mice results from the activation of I-A(g7)-restricted, islet-reactive T cells. This study delineates several characteristics of NOD CD4 T cell activation, which, independent of I-A(g7), are likely to promote a dysregulated state of peripheral T cell tolerance. NOD CD4 T cell activation was found to be resistant to antigenic stimulation via the TCR complex, using the progression of cell division as a measure. The extent of NOD CD4 T cell division was highly sensitive to changes in Ag ligand density. Moreover, even upon maximal TCR complex-mediated stimulation, NOD CD4 T cell division prematurely terminated. Maximally stimulated NOD CD4 T cells failed to achieve the threshold number of division cycles required for optimal susceptibility to activation-induced death, a critical mechanism for the regulation of peripheral T cell tolerance. Importantly, these aberrant activation characteristics were not T cell-intrinsic but resulted from reliance on B cell costimulatory function in NOD mice. Costimulation delivered by nonautoimmune strain APCs normalized NOD CD4 T cell division and the extent of activation-induced death. Thus, by disrupting the progression of CD4 T cell division, polarization of APC costimulatory function to the B cell compartment could allow the persistence and activation of diabetogenic cells in NOD mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035112     DOI: 10.4049/jimmunol.165.8.4685

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  Genetic separation of the transplantation tolerance and autoimmune phenotypes in NOD mice.

Authors:  Todd Pearson; Thomas G Markees; David V Serreze; Melissa A Pierce; Linda S Wicker; Laurence B Peterson; Leonard D Shultz; John P Mordes; Aldo A Rossini; Dale L Greiner
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

2.  Reduced diabetes in btk-deficient nonobese diabetic mice and restoration of diabetes with provision of an anti-insulin IgH chain transgene.

Authors:  Peggy L Kendall; Daniel J Moore; Chrys Hulbert; Kristen L Hoek; Wasif N Khan; James W Thomas
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

3.  Regulation of B lymphocyte responses to Toll-like receptor ligand binding during diabetes prevention in non-obese diabetic (NOD) mice.

Authors:  Christopher S Wilson; Sydney K Elizer; Andrew F Marshall; Blair T Stocks; Daniel J Moore
Journal:  J Diabetes       Date:  2015-03-03       Impact factor: 4.006

4.  Transient depletion of CD4+ CD25+ regulatory T cells results in multiple autoimmune diseases in wild-type and B-cell-deficient NOD mice.

Authors:  Jason S Ellis; Xiaoxiao Wan; Helen Braley-Mullen
Journal:  Immunology       Date:  2013-06       Impact factor: 7.397

Review 5.  Effector and regulatory B cells: modulators of CD4+ T cell immunity.

Authors:  Frances E Lund; Troy D Randall
Journal:  Nat Rev Immunol       Date:  2010-03-12       Impact factor: 53.106

6.  In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes.

Authors:  Daniel J Moore; Jozef Zienkiewicz; Peggy L Kendall; Danya Liu; Xueyan Liu; Ruth Ann Veach; Robert D Collins; Jacek Hawiger
Journal:  PLoS One       Date:  2010-10-06       Impact factor: 3.240

7.  Imbalance in Th cell polarization and its relevance in type 1 diabetes mellitus.

Authors:  Charles Sia
Journal:  Rev Diabet Stud       Date:  2006-02-10

8.  B cells in autoimmune diabetes.

Authors:  F Susan Wong; Li Wen
Journal:  Rev Diabet Stud       Date:  2005-11-10

Review 9.  The role of t/b lymphocyte collaboration in the regulation of autoimmune and alloimmune responses.

Authors:  Hooman Noorchashm; Siri A Greeley; Ali Naji
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

10.  Tolerant anti-insulin B cells are effective APCs.

Authors:  Peggy L Kendall; James B Case; Allison M Sullivan; Jeff S Holderness; K Sam Wells; Edwin Liu; James W Thomas
Journal:  J Immunol       Date:  2013-02-08       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.